Help : r/Semaglutide
US$ 24.12
glp 1 agonist gastric emptying Frontiers GLP-1 Receptor Agonists in Gastrointestinal
Description
Diabetes, Obesity and Metabolism, 24 (8), 1553-1564
ROR = 2.64, 95% CI 2.612.67) Metabolism and nutrition disorders (n = 10,775
Cost was also a notable barrier (12.8% of patients discontinued due to affordability)
Oral formulations overcome barriers associated with injectable drugs, offering greater convenience and acceptance among patients who are reluctant or unable to use injections
J Clin Invest 129: 37863791
H.KrishanS.AnwaarM
